Bio-Rad Laboratories Inc Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$547.25 | $591.94 | 10.83% | 1 | $208.89B |
| DHR | Danaher | Outperform |
10
|
$239.39 | $260.33 | 12.79% | 4 | $177.28B |
| A | Agilent Technologies | Outperform |
10
|
$134.55 | $138.82 | 12.60% | 10 | $39.43B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.20k | $1.12k | 2.67% | 0 | $25.62B |
| ILMN | Illumina | Outperform |
16
|
$118.29 | $159.28 | 27.72% | 9 | $18.84B |
| WAT | Waters | Hold |
15
|
$304.18 | $323.50 | 8.49% | 2 | $18.04B |
| AVTR | Avantor | Outperform |
16
|
$24.38 | $23.25 | 14.85% | 19 | $16.56B |
| PKI | PerkinElmer | Outperform |
16
|
$100.55 | $121.84 | 23.20% | 1 | $12.42B |
| BRKR | Bruker | Outperform |
16
|
$82.94 | $73.64 | 9.12% | 1 | $11.42B |
| COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.40 | $12.67 | 364.29% | 4 | $1.78B |
| LAB | Standard BioTools | Buy |
11
|
$2.61 | $4.00 | 34.10% | 1 | $686.85M |
| HBIO | Harvard Bioscience | Buy |
14
|
$4.09 | $7.00 | 71.15% | 2 | $191.82M |
| EQTL | Equitech International | - |
0
|
$1.40 | $0.00 | -100.00% | 0 | $2.56M |
| ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |